APA (7th ed.) Citation

Meng, F., Zhang, S., Xie, J., Zhou, Y., Wu, Q., Lu, B., . . . Li, Y. (2023). Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells. BMC.

Chicago Style (17th ed.) Citation

Meng, Fanyi, Siqi Zhang, Juan Xie, Yuan Zhou, Qingling Wu, Binyan Lu, Shixin Zhou, Xiangyu Zhao, and Yang Li. Leveraging CD16 Fusion Receptors to Remodel the Immune Response for Enhancing Anti-tumor Immunotherapy in IPSC-derived NK Cells. BMC, 2023.

MLA (9th ed.) Citation

Meng, Fanyi, et al. Leveraging CD16 Fusion Receptors to Remodel the Immune Response for Enhancing Anti-tumor Immunotherapy in IPSC-derived NK Cells. BMC, 2023.